Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury

Chronic kidney disease (CKD), which is associated with high morbidity, remains a worldwide health concern, while effective therapies remain limited. Hydroxychloroquine (HCQ), which mainly targets toll-like receptor-7 (TLR-7) and TLR-9, is associated with a lower risk of incident CKD. Taking into acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Haofeng, Zhang, Yannan, He, Jiannan, Yang, Zhe, Zhang, Rui, Li, Lei, Luo, Zihuan, Ye, Yongrong, Sun, Qiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079743/
https://www.ncbi.nlm.nih.gov/pubmed/33936063
http://dx.doi.org/10.3389/fimmu.2021.645100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079743/
https://www.ncbi.nlm.nih.gov/pubmed/33936063
http://dx.doi.org/10.3389/fimmu.2021.645100

Ejemplares similares